Back
Brookfield Infrastructure Partners LP Vs. Blueprint Medicines Industry Stock Comparison
Sell
44
BIP
Brookfield Infrastructure Partners LP
Last Price:
$32.20
Seasonality Move:
2.46%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
44
Brookfield Infrastructure Partners LP (BIP)
is a Sell
Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?
-
The current Brookfield Infrastructure Partners LP [BIP] share price is $32.29. The Score for BIP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIP Stock Price Chart
What is Brookfield Infrastructure Partners LP's stock price today?
-
The Brookfield Infrastructure Partners LP share price today is $32.29Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIP is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
BIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 40.48 | Sell |
Chaikin Money Flow: | -38260 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.45 - 33.49) | Sell |
Bollinger Bands (100): | (29.16 - 33.2) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.49 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.07 - 129.15) | Buy |
Bollinger Bands (100): | (85.79 - 122.45) | Buy |
BIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.44 | Sell |
20-day SMA: | 33 | Sell |
50-day SMA: | 32.94 | Sell |
200-day SMA: | 32.39 | Sell |
8-day EMA: | 32.52 | Sell |
20-day EMA: | 32.79 | Sell |
50-day EMA: | 32.53 | Sell |
200-day EMA: | 31.86 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.38 | Buy |
20-day SMA: | 128.73 | Buy |
50-day SMA: | 119.37 | Buy |
200-day SMA: | 99.85 | Buy |
8-day EMA: | 129.26 | Buy |
20-day EMA: | 127.9 | Buy |
50-day EMA: | 120.09 | Buy |
200-day EMA: | 103.72 | Buy |
Brookfield Infrastructure Partners LP Earnings Growth & BIP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.21 per share, an increase this year of $0.72 per share, and an increase next year of $0.09 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
Brookfield Infrastructure Partners LP Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |